Literature DB >> 7546681

Effects of irradiation on the rat middle ear mucosa. A scanning electron microscopic study.

W Y Chao1, H W Leung.   

Abstract

Adult Sprague-Dawley rats (n = 64) were used in this study to replicate in an animal model tissue change formed clinically during radiotherapy for the treatment of head and neck malignancy. Gamma irradiation was administered to both ears of each rat, using a cobalt-60 machine. A total dose of 30 Gy was administered, with 500 cGy/fraction given on 6 consecutive days to a time-dose fractionation value of 81. Animals were then sacrificed at sequential intervals. The tympanic bullae were removed and the mucosa was processed for scanning electron microscopy. Tissue findings indicated that irradiation might initially have no influence on the clearance activity of the middle ear. However, ultrastructural changes showed stagnation of secretion between cilia, falling off and different directions of the cilia, fused or collapsed cilia, and eustachian tube dysfunction (with mucosal edema). These findings possibly account for the occurrence of middle ear effusions in patients during and after radiotherapy for head and neck malignancy. It is our concept that insertion of a ventilation tube is necessary if abnormal mucociliary function appears, in order to clear and prevent the accumulation of any middle ear effusions and prevent further mucociliary dysfunction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7546681     DOI: 10.1007/bf00179919

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  13 in total

1.  Effect of irradiation on middle ear effusion due to nasopharyngeal carcinoma.

Authors:  S K Lau; W I Wei; J Sham; Y Hui; D Choy
Journal:  Clin Otolaryngol Allied Sci       Date:  1992-06

2.  A study of the late effects of radiotherapy and operation on patients with maxillary cancer. A survey more than 10 years after initial treatment.

Authors:  S Sakai; T Kubo; N Mori; M Itoh; M Miyaguchi; S Kitaoku; Y Sakata; H Fuchihata
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

3.  Irradiation of the ear.

Authors:  W Leach
Journal:  J Laryngol Otol       Date:  1965-10       Impact factor: 1.469

4.  Effects of irradiation on the ciliary activity of the eustachian tube and the middle ear mucosa.

Authors:  Y Ohashi; Y Nakai; H Ikeoka; H Koshimo; Y Onoyama
Journal:  Arch Otorhinolaryngol       Date:  1985

5.  Carcinoma of the nasopharynx. Eighteen years' experience with megavoltage radiation therapy.

Authors:  R T Hoppe; D R Goffinet; M A Bagshaw
Journal:  Cancer       Date:  1976-06       Impact factor: 6.860

6.  Protease inhibitors in middle ear effusions.

Authors:  B Carlsson; C Lundberg; K Ohlsson
Journal:  Ann Otol Rhinol Laryngol       Date:  1981 Jan-Feb       Impact factor: 1.547

7.  Delayed ultrastructural radiation induced changes in the human mesotympanic middle ear mucosa.

Authors:  S Elwany
Journal:  J Laryngol Otol       Date:  1985-04       Impact factor: 1.469

8.  Immune complexes in middle ear fluid in chronic secretory otitis media.

Authors:  T Palva; T Lehtinen; J Rinne
Journal:  Ann Otol Rhinol Laryngol       Date:  1983 Jan-Feb       Impact factor: 1.547

9.  Prospective study of the effects of ventilation tubes on hearing after radiotherapy for carcinoma of nasopharynx.

Authors:  C R Chowdhury; J H Ho; A Wright; S Y Tsao; G K Au; Y Tung
Journal:  Ann Otol Rhinol Laryngol       Date:  1988 Mar-Apr       Impact factor: 1.547

10.  Lysosomal hydrolases in middle ear effusions.

Authors:  W F Diven; R H Glew; C D Bluestone
Journal:  Ann Otol Rhinol Laryngol       Date:  1981 Mar-Apr       Impact factor: 1.547

View more
  1 in total

1.  Long-term result of management of otitis media with effusion in patients with post-irradiated nasopharyngeal carcinoma.

Authors:  Kai-Li Liang; Mao-Chang Su; Chih-Wen Twu; Rong-San Jiang; Jin-Ching Lin; Jiun-Yih Shiao
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-15       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.